Title: Stephen Grimes: Innovator in Immunogenic Compositions
Introduction
Stephen Grimes is an accomplished inventor based in the United States. He has made significant contributions to the field of immunogenic compositions, particularly in the treatment of ulcers and tumors influenced by gastrin hormones. His innovative work has the potential to impact therapeutic approaches in this area.
Latest Patents
Stephen Grimes holds a patent titled "Immunogenic Compositions Against Gastrin Peptides." This patent discloses immunogenic compositions that are useful for treating ulcers or tumors whose growth is dependent on or stimulated by gastrin hormones. The compositions induce antibodies in a subject that selectively neutralize specific hormones. Additionally, the patent outlines pharmaceutical compositions comprising effective amounts of these immunogenic compositions and methods of treatment using them. A method for reversing the treatments by neutralizing the antibodies induced in vivo is also included.
Career Highlights
Throughout his career, Stephen Grimes has worked with notable companies, including Philip C. Gevas and Stephen L. Karr. His experience in these organizations has contributed to his expertise in the field of immunogenic compositions.
Collaborations
Stephen has collaborated with professionals such as Philip C. Gevas and Jr. Karr Stephen L. These collaborations have likely enriched his research and development efforts.
Conclusion
Stephen Grimes is a notable inventor whose work in immunogenic compositions has the potential to advance treatment options for conditions related to gastrin hormones. His contributions to the field are significant and reflect his dedication to innovation.